Pamiparib
- CAS No.
- 1446261-44-4
- Chemical Name:
- Pamiparib
- Synonyms
- Pamiparib;bgb-290;EOS-61090;Pamiparib(BGB290);BGB-290,Pamiparib;Alflutinib Impurity 17;PAMIPARIB; BGB-290; BGB 290; BGB290.;inhibit,Pamiparib,PARP,Inhibitor,poly ADP ribose polymerase,BGB 290,BGB290;(R)-2-fluoro-10a-methyl-5,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(7H)-one;(R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one
- CBNumber:
- CB13137483
- Molecular Formula:
- C16H15FN4O
- Molecular Weight:
- 298.31
- MOL File:
- 1446261-44-4.mol
- Modify Date:
- 2024/11/18 17:01:59
Density | 1.68±0.1 g/cm3(Predicted) |
---|---|
storage temp. | Store at -20°C |
solubility |
DMF:20.0(Max Conc. mg/mL);67.04(Max Conc. mM) DMF:PBS (pH 7.2) (1:10):0.09(Max Conc. mg/mL);0.3(Max Conc. mM) DMSO:40.83(Max Conc. mg/mL);136.88(Max Conc. mM) Ethanol:45.0(Max Conc. mg/mL);150.84(Max Conc. mM) |
form | A solid |
pka | 11.56±0.40(Predicted) |
color | Light yellow to yellow |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS05,GHS06,GHS02 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Danger | |||||||||
Hazard statements | H300+H310+H330-H314-H226 | |||||||||
Precautionary statements | P501-P260-P270-P262-P240-P210-P233-P243-P241-P242-P271-P264-P280-P284-P370+P378-P361+P364-P303+P361+P353-P301+P330+P331-P301+P310+P330-P304+P340+P310-P305+P351+P338+P310-P403+P233-P403+P235-P405 | |||||||||
NFPA 704 |
|
Pamiparib Chemical Properties,Uses,Production
Description
Pamiparib (BGB-290) is an investigational small molecule inhibitor of PARP1 and PARP2. Pamiparib is being evaluated as a monotherapy in pivotal clinical trials in China in recurrent platinum-sensitive and BRCA1/2 mutated ovarian cancers.
in vivo
Oral administration of Pamiparib results in time-dependent and dose-dependent inhibition of PARylation in MDA-MB-436 (BRCA1 mutant) breast cancer xenograft, correlating well with the tumor drug concentrations. It has also demonstrated good combination activity with chemotherapeutics in patient biopsy derived SCLC models. Also Pamiparib has significant brain penetration in C57 mice. The drug exposure in brain vs. that in plasma was close to 20% after oral administration of BGB-290.
Pamiparib Preparation Products And Raw materials
Pamiparib Suppliers
Global( 80)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
SRI ANAGHA BIOSCIENCES PVT LTD | +91-9959644262 +91-9959644262 | Telangana, India | 25 | 58 | Inquiry |
BOC Sciences | +1-631-485-4226 | United States | 19553 | 58 | Inquiry |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | United States | 32161 | 58 | Inquiry |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | China | 10473 | 58 | Inquiry |
InvivoChem | +1-708-310-1919 +1-13798911105 | United States | 6391 | 58 | Inquiry |
LEAP CHEM CO., LTD. | +86-852-30606658 | China | 24727 | 58 | Inquiry |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | China | 49734 | 58 | Inquiry |
TargetMol Chemicals Inc. | United States | 38631 | 58 | Inquiry | |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | China | 8467 | 58 | Inquiry |
Nanjing Bicbiotechnology Co., Ltd | +86-2552131256 +86-18251840740 | China | 5994 | 58 | Inquiry |
(R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one
(R)-2-fluoro-10a-methyl-5,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(7H)-one
5,6,7a,11-Tetraazacyclohepta[def]cyclopenta[a]fluoren-4(7H)-one, 2-fluoro-5,8,9,10,10a,11-hexahydro-10a-methyl-, (10aR)-
PAMIPARIB; BGB-290; BGB 290; BGB290.
BGB-290,Pamiparib
Pamiparib(BGB290)
EOS-61090
bgb-290
Pamiparib
inhibit,Pamiparib,PARP,Inhibitor,poly ADP ribose polymerase,BGB 290,BGB290
(2R)-14-fluoro-2-methyl-6,9,10,19-tetraazapentacyclo[14.2.1.02,?.0?,1?.012,1?]nonadeca-1(18),8,12(17),13,15-pentaen-11-one
Alflutinib Impurity 17
1446261-44-4
1446261-44-1
APIS